Prabhu Seshaiyer Bhagavatheeswaran

Title: Prabhu Seshaiyer Bhagavatheeswaran: Innovator in Tumor Treatment

Introduction

Prabhu Seshaiyer Bhagavatheeswaran is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of cancer treatment, particularly in addressing small cell lung cancer (SCLC). His innovative approach focuses on utilizing advanced therapies to improve patient outcomes.

Latest Patents

Prabhu holds 1 patent for his work titled "Methods of treating tumor." This patent discloses a method for treating subjects afflicted with tumors derived from SCLC that have a high tumor mutational burden (TMB) status. The method involves administering a monotherapy comprising an anti-PD-1 antibody or a combination therapy that includes both an anti-PD-1 antibody and an anti-CTLA-4 antibody. Additionally, the patent outlines a method for identifying suitable subjects for treatment by measuring the TMB status of a biological sample, which can be determined through sequencing nucleic acids in the tumor.

Career Highlights

Prabhu Seshaiyer Bhagavatheeswaran is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research in oncology. His work is pivotal in developing targeted therapies that can significantly enhance the effectiveness of cancer treatments.

Collaborations

Prabhu collaborates with esteemed colleagues, including Nicholas Allan John Botwood and Han Chang. These partnerships foster a collaborative environment that encourages innovation and the sharing of ideas in the field of cancer research.

Conclusion

Prabhu Seshaiyer Bhagavatheeswaran is a dedicated inventor whose work in tumor treatment is making a meaningful impact in oncology. His innovative methods and collaborations are paving the way for advancements in cancer therapies.